S-budesonide |
|
White powder |
|
51333-22-3 |
|
Budesonide is a glucocorticoid steroid used in inhaled formulations for the treatment of asthma, COPD and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. It is also used in a delayed-release oral formulations for inflammatory bowel disease including Crohn's disease and ulcerative colitis. |
|
Product Name: S-budesonide Synonyms: Budesonide (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one CAS: 51333-22-3 EINECS: 257-139-7 MF: C25H34O6 MW: 430.5339 Assay: 98% Appearance: White powder
Density 1.27g/cm3 Boiling point 599.7¡ÆC at 760 mmHg Refractive index 1.592 Flash point 201.8¡ÆC Vapour Pressur 6.94E-17mmHg at 25¡ÆC
2. Descriptions:
Budesonide is a glucocorticoid steroid used in inhaled formulations for the treatment of asthma, COPD and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. It is also used in a delayed-release oral formulations for inflammatory bowel disease including Crohn's disease and ulcerative colitis.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|